OKYO Pharma expands scientific advisory board with cornea expert

OKYO Pharma appointed Dr. Marta Sacchetti to its scientific advisory board as it advances development of its lead ophthalmic candidate for neuropathic corneal pain. The update is a modest corporate and R&D progress item rather than a clinical or financial catalyst. No trial data, regulatory decision, or financing details were disclosed.

Analysis

OKYO Pharma appointed Dr. Marta Sacchetti to its scientific advisory board as it advances development of its lead ophthalmic candidate for neuropathic corneal pain. The update is a modest corporate and R&D progress item rather than a clinical or financial catalyst. No trial data, regulatory decision, or financing details were disclosed.